Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
OPERATING ACTIVITIES    
Net income (loss) $ 1,017 $ (267)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Provision for doubtful accounts 69 45
Depreciation 3,044 3,072
Loss on disposal of and reserve adjustments for medical equipment 202 257
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 123 (838)
Amortization of intangible assets 209 248
Amortization of deferred debt issuance costs 21 19
Stock-based compensation 1,233 1,108
Deferred income taxes 400 520
Changes in assets - (increase)/decrease:    
Accounts receivable (2,250) (2,095)
Inventories (203) 433
Other current assets (130) 126
Other assets 563 729
Changes in liabilities - (decrease)/increase:    
Accounts payable and other liabilities (3,328) (1,577)
NET CASH PROVIDED BY OPERATING ACTIVITIES 970 1,780
INVESTING ACTIVITIES    
Purchase of medical equipment (1,680) (3,284)
Purchase of property and equipment (157) (131)
Proceeds from sale of medical equipment, property and equipment 577 754
NET CASH USED IN INVESTING ACTIVITIES (1,260) (2,661)
FINANCING ACTIVITIES    
Principal payments on long-term debt (6,145) (14,407)
Cash proceeds from long-term debt 6,145 19,231
Common stock repurchased as part of share repurchase program (809) (2,895)
Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans (165) (228)
Cash proceeds from exercise of options and ESPP 184 159
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (790) 1,860
Net change in cash and cash equivalents (1,080) 979
Cash and cash equivalents, beginning of period 3,186 527
Cash and cash equivalents, end of period $ 2,106 $ 1,506